Sutro Biopharma (STRO) EPS (2020 - 2026)
Sutro Biopharma (STRO) EPS from Jun 30, 2020 to Mar 31, 2026. The TTM Sutro Biopharma (STRO) EPS is -$15.81. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Sutro Biopharma (STRO) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -46.54% |
| 3 Years TTM | -12.06% |
| 5 Years TTM | +18.47% |
| All Time TTM | -0.81% |
Annual EPS change of Sutro Biopharma (STRO)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$2.32 | -89.57% |
| 2025 | -$22.26 | -18.71% |
| 2024 | -$27.38 | +56.44% |
| 2023 | -$17.50 | -15.57% |
| 2022 | -$20.73 | -9.00% |
| 2021 | -$22.78 | +224.40% |
| 2020 | -$7.02 | -86.39% |
| 2019 | -$51.60 | +233.82% |
| 2018 | -$15.46 | -63.47% |
| 2017 | -$42.31 | N/A |
Comparison Sutro Biopharma (STRO) five years EPS CAGR with competitors
Sutro Biopharma (STRO) five years EPS CAGR is 18.47%.